In Part 2 of his interview with Mayo Clinic Proceedings regarding his review article on H1N1 to be published ahead of print in early December 2009 (with final publication in January 2010 issue), Dr. Greg Poland, Professor of Medicine and Infectious Diseases at Mayo Clinic and Director of the Mayo Vaccine Research Group, addresses primarily a health care professional audience and discusses the likelihood that the H1N1 will become part of the seasonal vaccine next year, when to provide/seek treatment with antiviral agents, the usefulness of antiviral treatment even after the ideal 48-hour window has passed, the speed of progression of the disease, and the importance for health care workers to be vaccinated.
Link to this comment:
All Comments (0)